
Join to view full profile
1 Hospital DrColumbia, MO 65212
Phone+1 573-884-7770
Fax+1 573-882-9879
Dr. Abdelhakiem is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mohamed Abdelhakiem is a radiation oncologist based in Columbia, MO. He graduated in 2017 from the Medical College of Wisconsin and completed his residency in Radiation Oncology at UPMC Medical Education, spanning 2020 to 2024. His research contributions, which include several published articles, primarily focus on cancer treatment and its effects. Some of his work has been published in journals such as Cancers, Clinical Cancer Research, Brachytherapy, and Radiotherapy and Oncology.
Education & Training
UPMC Medical EducationResidency, Radiation Oncology, 2020 - 2024
Medical College of WisconsinClass of 2017
Certifications & Licensure
MO State Medical License 2024 - 2027
PA State Medical License 2020 - 2024
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 2 citationsLessons Learned About Acute and Late Toxicity After Two Decades of Experience With Pancreatic SBRT.Susannah G Ellsworth, Mohamed Abdelhakiem, Baher Elgohari, Mohammed Mohammed, Jeffrey Shogan
Journal of the National Comprehensive Cancer Network. 2025-06-11 - 2 citationsTh2 Cells Are Associated with Tumor Recurrence Following Radiation.Mohamed K Abdelhakiem, Riyue Bao, Phillip M Pifer, David Molkentine, Jessica Molkentine
Cancers. 2024-04-20 - 8 citationsFAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.Phillip M Pifer, Liangpeng Yang, Manish Kumar, Tongxin Xie, Mitchell Frederick
Clinical Cancer Research. 2024-01-05
Press Mentions
- Study Identifies Cancer Features That Could Guide Personalized RadiotherapyNovember 3rd, 2021
Perspective Therapeutics’ Cesium-131 Featured at the American Society for Radiation Oncology’s Annual ConferenceOctober 7th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









